Shlomo Wagner

Prof. Shlomo Wagner

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 1997 in Nature
Verified
Journal Article
Closed access
PDF file
SWShlomo Wagner
Shlomo Wagner
MCMona Castel
Mona Castel
HGHarold Gainer
Harold Gainer
YYYosef Yarom
Yosef Yarom

1 December 2006 in Annual Review of Genetics
Verified
Journal Article
Closed access
CDC. Dulac
C. Dulac
SWShlomo Wagner
Shlomo Wagner
Molecular approaches and genetic manipulations have provided novel insights into the processing of pheromone-mediated information by the olfactory and vomeronasal systems of mammals. We will review and discuss the specific contribution of each of the two chemosensory systems that ensure specific behavioral responses to conspecific animals.

27 July 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YTYan Tang
Yan Tang
DBDiego Benusiglio
Diego Benusiglio
ALArthur Lefevre
Arthur Lefevre
LHLouis Hilfiger
Louis Hilfiger
FAFerdinand Althammer
Ferdinand Althammer
VGValery Grinevich
Valery Grinevich

1 September 2014 in Biological Psychiatry
Verified
Journal Article
Closed access
RGRotem Gur
Rotem Gur
ATAlex Tendler
Alex Tendler
SWShlomo Wagner
Shlomo Wagner

1 June 2006 in Neuron
Verified
Journal Article
Closed access
SWShlomo Wagner
Shlomo Wagner
AGAmy L. Gresser
Amy L. Gresser
ATA. Thomas Torello
A. Thomas Torello
CDCatherine Dulac
Catherine Dulac

31 January 2017 in eLife
Verified
Journal Article
Open access
HHHala Harony-Nicolas
Hala Harony-Nicolas
MKMaya Kay
Maya Kay
JHJohann du Hoffmann
Johann du Hoffmann
MKMatthew E Klein
Matthew E Klein
OBOzlem Bozdagi-Gunal
Ozlem Bozdagi-Gunal
JBJoseph D Buxbaum
Joseph D Buxbaum
Mutations in the synaptic gene SHANK3 lead to a neurodevelopmental disorder known as Phelan-McDermid syndrome (PMS). PMS is a relatively common monogenic and highly penetrant cause of autism spectrum disorder (ASD) and intellectual disability (ID), and frequently presents with attention deficits. The underlying neurobiology of PMS is not fully known and pharmacological treatments for core symptoms do not exist. Here, we report the production and characterization of a Shank3-deficient rat model of PMS, with a genetic alteration similar to a human SHANK3 mutation. We show that Shank3-deficient rats exhibit impaired long-term social recognition memory and attention, and reduced synaptic plasticity in the hippocampal-medial prefrontal cortex pathway. These deficits were attenuated with oxytocin treatment. The effect of oxytocin on reversing non-social attention deficits is a particularly novel finding, and the results implicate an oxytocinergic contribution in this genetically defined subtype of ASD and ID, suggesting an individualized therapeutic approach for PMS.